Brett M Loffredo, MD - Medicare Family Practice in Gorham, ME

Brett M Loffredo, MD is a medicare enrolled "Family Medicine" physician in Gorham, Maine. He went to Boston University School Of Medicine and graduated in 2004 and has 20 years of diverse experience with area of expertise as Family Practice. He is a member of the group practice Mainehealth and his current practice location is 94 Main St, Gorham, Maine. You can reach out to his office (for appointments etc.) via phone at (207) 839-5225.

Brett M Loffredo is licensed to practice in Maine (license number 017417) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1295809911.

Contact Information

Brett M Loffredo, MD
94 Main St,
Gorham, ME 04038
(207) 839-5225
(207) 839-7850



Physician's Profile

Full NameBrett M Loffredo
GenderMale
SpecialityFamily Practice
Experience20 Years
Location94 Main St, Gorham, Maine
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Brett M Loffredo attended and graduated from Boston University School Of Medicine in 2004
  NPI Data:
  • NPI Number: 1295809911
  • Provider Enumeration Date: 11/17/2006
  • Last Update Date: 08/31/2011
  Medicare PECOS Information:
  • PECOS PAC ID: 0547352866
  • Enrollment ID: I20070816000362

Medical Identifiers

Medical identifiers for Brett M Loffredo such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1295809911NPI-NPPES
432600199MedicaidME

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 017417 (Maine)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Southern Maine Health CareBiddeford, MEHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Mainehealth75178605882067

News Archive

Exposure to endocrine-disrupting chemicals estimated to cost EU €157 billion a year

A new economic analysis found exposure to endocrine-disrupting chemicals likely costs the European Union €157 billion ($209 billion) a year in actual health care expenses and lost earning potential, according to a new series of studies published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism.

Immunoassay heterogeneity and implications for SARS-CoV-2 serosurveillance

In a recent study, scientists have quantified anti-SARS-CoV-2 antibody levels up to 9 months after infection.

SARS-CoV-2 reinfection and the natural immune response

Researchers review available literature on immunity and SARS-CoV-2 infection to elucidate mechanisms behind SARS-CoV-2 immunity and reinfections.

Specific drug regimen taken prior to surgery reduces risk of cancer recurrence, study finds

Most cancer-related deaths are the result of post-surgical metastatic recurrence. In metastasis, cells of primary tumors travel to other parts of the body, where they often proliferate into inoperable, ultimately fatal growths.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Brett M Loffredo allows following entities to bill medicare on his behalf.
Entity NameMaine Medical Partners
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1467477349
PECOS PAC ID: 9335043967
Enrollment ID: O20031125000026

News Archive

Exposure to endocrine-disrupting chemicals estimated to cost EU €157 billion a year

A new economic analysis found exposure to endocrine-disrupting chemicals likely costs the European Union €157 billion ($209 billion) a year in actual health care expenses and lost earning potential, according to a new series of studies published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism.

Immunoassay heterogeneity and implications for SARS-CoV-2 serosurveillance

In a recent study, scientists have quantified anti-SARS-CoV-2 antibody levels up to 9 months after infection.

SARS-CoV-2 reinfection and the natural immune response

Researchers review available literature on immunity and SARS-CoV-2 infection to elucidate mechanisms behind SARS-CoV-2 immunity and reinfections.

Specific drug regimen taken prior to surgery reduces risk of cancer recurrence, study finds

Most cancer-related deaths are the result of post-surgical metastatic recurrence. In metastasis, cells of primary tumors travel to other parts of the body, where they often proliferate into inoperable, ultimately fatal growths.

Read more Medical News

› Verified 9 days ago

Entity NameMainehealth
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1639194509
PECOS PAC ID: 7517860588
Enrollment ID: O20040206000472

News Archive

Exposure to endocrine-disrupting chemicals estimated to cost EU €157 billion a year

A new economic analysis found exposure to endocrine-disrupting chemicals likely costs the European Union €157 billion ($209 billion) a year in actual health care expenses and lost earning potential, according to a new series of studies published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism.

Immunoassay heterogeneity and implications for SARS-CoV-2 serosurveillance

In a recent study, scientists have quantified anti-SARS-CoV-2 antibody levels up to 9 months after infection.

SARS-CoV-2 reinfection and the natural immune response

Researchers review available literature on immunity and SARS-CoV-2 infection to elucidate mechanisms behind SARS-CoV-2 immunity and reinfections.

Specific drug regimen taken prior to surgery reduces risk of cancer recurrence, study finds

Most cancer-related deaths are the result of post-surgical metastatic recurrence. In metastasis, cells of primary tumors travel to other parts of the body, where they often proliferate into inoperable, ultimately fatal growths.

Read more Medical News

› Verified 9 days ago

Entity NameMaine Medical Partners
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1598780447
PECOS PAC ID: 9335043967
Enrollment ID: O20040220000847

News Archive

Exposure to endocrine-disrupting chemicals estimated to cost EU €157 billion a year

A new economic analysis found exposure to endocrine-disrupting chemicals likely costs the European Union €157 billion ($209 billion) a year in actual health care expenses and lost earning potential, according to a new series of studies published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism.

Immunoassay heterogeneity and implications for SARS-CoV-2 serosurveillance

In a recent study, scientists have quantified anti-SARS-CoV-2 antibody levels up to 9 months after infection.

SARS-CoV-2 reinfection and the natural immune response

Researchers review available literature on immunity and SARS-CoV-2 infection to elucidate mechanisms behind SARS-CoV-2 immunity and reinfections.

Specific drug regimen taken prior to surgery reduces risk of cancer recurrence, study finds

Most cancer-related deaths are the result of post-surgical metastatic recurrence. In metastasis, cells of primary tumors travel to other parts of the body, where they often proliferate into inoperable, ultimately fatal growths.

Read more Medical News

› Verified 9 days ago

Entity NameMainehealth
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1790265502
PECOS PAC ID: 7517860588
Enrollment ID: O20040701000166

News Archive

Exposure to endocrine-disrupting chemicals estimated to cost EU €157 billion a year

A new economic analysis found exposure to endocrine-disrupting chemicals likely costs the European Union €157 billion ($209 billion) a year in actual health care expenses and lost earning potential, according to a new series of studies published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism.

Immunoassay heterogeneity and implications for SARS-CoV-2 serosurveillance

In a recent study, scientists have quantified anti-SARS-CoV-2 antibody levels up to 9 months after infection.

SARS-CoV-2 reinfection and the natural immune response

Researchers review available literature on immunity and SARS-CoV-2 infection to elucidate mechanisms behind SARS-CoV-2 immunity and reinfections.

Specific drug regimen taken prior to surgery reduces risk of cancer recurrence, study finds

Most cancer-related deaths are the result of post-surgical metastatic recurrence. In metastasis, cells of primary tumors travel to other parts of the body, where they often proliferate into inoperable, ultimately fatal growths.

Read more Medical News

› Verified 9 days ago

Entity NameMaine Medical Partners
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1073527388
PECOS PAC ID: 9335043967
Enrollment ID: O20050401000844

News Archive

Exposure to endocrine-disrupting chemicals estimated to cost EU €157 billion a year

A new economic analysis found exposure to endocrine-disrupting chemicals likely costs the European Union €157 billion ($209 billion) a year in actual health care expenses and lost earning potential, according to a new series of studies published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism.

Immunoassay heterogeneity and implications for SARS-CoV-2 serosurveillance

In a recent study, scientists have quantified anti-SARS-CoV-2 antibody levels up to 9 months after infection.

SARS-CoV-2 reinfection and the natural immune response

Researchers review available literature on immunity and SARS-CoV-2 infection to elucidate mechanisms behind SARS-CoV-2 immunity and reinfections.

Specific drug regimen taken prior to surgery reduces risk of cancer recurrence, study finds

Most cancer-related deaths are the result of post-surgical metastatic recurrence. In metastasis, cells of primary tumors travel to other parts of the body, where they often proliferate into inoperable, ultimately fatal growths.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Brett M Loffredo is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Brett M Loffredo, MD
301 Us Route 1, Building C,
Scarborough, ME 04074-7609

Ph: (207) 396-8600
Brett M Loffredo, MD
94 Main St,
Gorham, ME 04038

Ph: (207) 839-5225

News Archive

Exposure to endocrine-disrupting chemicals estimated to cost EU €157 billion a year

A new economic analysis found exposure to endocrine-disrupting chemicals likely costs the European Union €157 billion ($209 billion) a year in actual health care expenses and lost earning potential, according to a new series of studies published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism.

Immunoassay heterogeneity and implications for SARS-CoV-2 serosurveillance

In a recent study, scientists have quantified anti-SARS-CoV-2 antibody levels up to 9 months after infection.

SARS-CoV-2 reinfection and the natural immune response

Researchers review available literature on immunity and SARS-CoV-2 infection to elucidate mechanisms behind SARS-CoV-2 immunity and reinfections.

Specific drug regimen taken prior to surgery reduces risk of cancer recurrence, study finds

Most cancer-related deaths are the result of post-surgical metastatic recurrence. In metastasis, cells of primary tumors travel to other parts of the body, where they often proliferate into inoperable, ultimately fatal growths.

Read more News

› Verified 9 days ago


Family Medicine Doctors in Gorham, ME

Linda F Sanborn, MD
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 94 Main St, Gorham, ME 04038
Phone: 207-839-5225    Fax: 207-839-7850
Tin Ha Ngoc, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 575 Main St, Gorham, ME 04038
Phone: 207-839-2559    Fax: 207-523-1135
Michelle Garcia, MD
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 19 S Gorham Xing, Gorham, ME 04038
Phone: 207-535-1400    Fax: 207-535-1439
Dr. Megan Driscoll, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 575 Main Street, Gorham, ME 04038
Phone: 207-839-2559    Fax: 207-523-1135
Dr. Andrew Stuart Nicholson, M.D.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 130 Main St, Gorham, ME 04038
Phone: 207-839-5551    
Tiffany P Segre, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 94 Main St, Gorham, ME 04038
Phone: 207-839-5225    Fax: 207-839-7850

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.